Nav: Home

Maintaining a healthy heart through bile acids

July 27, 2016

(Edmonton, AB) Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis--a condition leading to heart failure for which there is currently no treatment.

The collaborative study, funded by the Canadian Institutes of Health Research and published in PLOS One, examined the molecular mechanisms that lead to cardiac fibrosis in a pre-clinical model. The study discovered the specific triggers activating the development of fibrosis which accelerates heart failure. Blocking the triggers through the use of a specific kind of bile acid prevented cardiac fibrosis from occurring.

"This is something that nobody has ever seen before," says Marek Michalak, co-principal investigator and a distinguished professor in the Department of Biochemistry at the University of Alberta's Faculty of Medicine & Dentistry. "Cardiac fibrosis is considered a permanent remodeling of the heart. Inevitably it leads to heart failure and eventually death. The bottom line is that this shows for the first time that cardiac fibrosis is preventable."

"It offers hope to those who are living with heart failure," adds Luis Agellon, co-principal investigator and a professor at McGill University's School of Dietetics and Human Nutrition. "Prevention of fibrosis will extend the ability of the heart to function, even if at a reduced capacity. Currently patients with heart failure have poor quality of life and a dismal prognosis. Improving their quality of life will do wonders for these individuals."

Fibrosis is an early step on the path to heart failure. According to the Heart and Stroke Foundation there are currently 1.3 million Canadians living with heart disease or heart failure--a condition that severely limits physical activity because the heart cannot pump enough oxygenated blood that the body needs. About 30 per cent of patients diagnosed with heart failure will die within the first year.

Cardiac fibrosis itself is caused by a variety of factors including high blood pressure, overwork of cardiac muscle and long-term consumption of a diet that is high in both saturated fat and sugar--all cause increased stress to heart cells. Individuals with diabetes, cancer patients undergoing chemotherapy and heart transplant recipients are also known to be at high risk.

"It's almost like building a scar," says Michalak. "It's exactly the same type of biological activity but it's happening in the heart tissue. It destroys the ability of the heart to function normally."

The team is now pushing forward with additional studies to see if the same therapeutic effect can be achieved in humans. They also aim to gain a better understanding of exactly how bile acids can prevent cardiac fibrosis from occurring.

"We don't yet have a full understanding--nobody does--of how the bile acid actually does what it does in heart cells," explains Michalak. "So, another phase of the work is to find out what actually happens within heart cells at the molecular level. How can this bile acid affect the heart in such a dramatic way?"

Once that occurs, the team hopes to work with cardiologists to quickly move the research into clinical trials, involving chemotherapy and heart transplant patients.

"If cardiac fibrosis can be stopped, then that could substantially improve the outcome for people at risk," says Agellon. "This would be a significant advance in the fight against heart disease."
-end-
This research was supported by the Canadian Institutes of Health Research.

"Inhibition of the Unfolded Protein Response Mechanism Prevents Cardiac Fibrosis," PLOS ONE, published online July 21, 2016.

University of Alberta Faculty of Medicine & Dentistry

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab